SUPERA S-45-060-120-P6 (UDI 08717648225949)Recalls & reported problems
Abbott Vascular Inc. · Supera Peripheral Stent System 4.5 mm x 60 mm x 120 cm 6 F · Class 3 · Implant
All models of SUPERA (55)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 08717648225949), received between Aug 29, 2019 and May 22, 2024 — classified as 2 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Material Separation” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Material Separation4
- Improper or Incorrect Procedure or Method3
- Difficult to Remove2
- Break1
- Device Dislodged or Dislocated1
- Difficult to Advance1
- Failure to Advance1
- Leak/Splash1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- Foreign Body In Patient1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 22, 2024Premature Activation; Difficult to Remove; Material Separation; Difficult to Advance; Material Deformation; Premature Activation; Difficult to Remove; Material Separation; Difficult to Advance; Material Deformation
SUBSEQUENT TO THE INITIALLY FILED MDR REPORT, RETURNED DEVICE ANALYSIS IDENTIFIED THAT THE TIP WAS SEPARATED AND NOT RETURNED. FOLLOW UP FOUND THAT THE ACCOUNT WAS AWARE OF THE SEPARATION, AS IT OCCURRED DURING REMOVAL OF THE SUPERA STENT DELIVERY SYSTEM WHEN THE NOSE CONE CAUGHT ON THE SHEATH. THE SEPARATED TIP WAS REMOVED WHEN BOTH DEVICES WERE REMOVED TOGETHER. THE SEPARATED TIP WAS DISCARDED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19374792 ↗InjuryDec 27, 2023Material Separation; Improper or Incorrect Procedure or Method; Failure to Advance; Device Dislodged or Dislocated; Material Separation; Improper or Incorrect Procedure or Method; Failure to Advance; Device Dislodged or Dislocated
USER FACILITY MEDWATCH REPORT (MW5148102) RECEIVED STATING: ABBOTT SUPERA STENT DELIVERY DEVICE WAS INSERTED OVER THE WIRE AND WAS UNABLE TO CROSS THE LESION. THE DEVICE WAS REMOVED. CARDIOLOGIST NOTICED A PIECE OF THE DELIVERY SYSTEM MISSING AND THE STENT WAS OFF THE DELIVERY DEVICE. THE MISSING PIECE WAS SNARED AND RETRIEVED. ADDITIONAL INFORMATION RECEIVED FROM THE SITE: THE VESSEL TREATED WAS THE DISTAL LEFT POPLITEAL ARTERY THAT IS SEVERELY DISEASED AT 90-95%. THERE WAS RESISTANCE DURING ADVANCEMENT AND FAILED TO CROSS DUE TO THE ANATOMY. NOTHING REMAINS IN THE PATIENT. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18401390 ↗InjuryFeb 10, 2023Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT THE POPLITEAL AND DISTAL FEMORAL ARTERY (SFA) VIA A DIRECT STICK TO THE POPLITEAL THROUGH A BYPASS GRAFT. THE VESSEL DIAMETER WAS 4-4.5MM, AND THE ATHERECTOMY WAS NOT USED. DURING PREPARATION OF A 4.5X40MM SUPERA SELF EXPANDING STENT (SSES) THE NOSECONE APPEARANCE DID NOT LIKE HOW IT LOOKED THEREFORE WAS NOT USED IN THE PATIENT. ANOTHER 4.5X60MM SUPERA SSES WAS PREPARED, AND THE VESSEL WAS PREPARED WITH A BALLOON DILATATION. THE STENT WAS DEPLOYED; AND DURING REMOVAL UNDER FLUOROSCOPY, THE RED LEVERS WERE NOT LOCKED BEFORE THE CATHETER WAS BEING PULLED OUT, THE NOSECONE GOT STUCK ON THE STENT STRUT AND THEN DETACHED. THE NOSECONE WAS UNABLE TO BE REMOVED FROM THE LOCATION. THE DELIVERY SYSTEM WAS REMOVED UNDER FLUOROSCOPY. THE NOSECONE REMAINS IN THE PERONEAL ARTERY; HOWEVER, THE ARTERY WAS CONFIRMED TO BE PATENT. THERE WERE NO REPORTED ADVERSE PATIENT SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED. RETURNED DEVICE ANALYSIS OF THE 4.5X40 SUPERA SESS IDENTIFIED A SEPARATED TIP WHICH WAS NOT RETURNED. THE ACCOUNT STATED IT WAS LIKELY DISCARDED.
Patient problems: Foreign Body In Patient
MAUDE report 16354389 ↗MalfunctionApr 5, 2022Material Separation; Material Separation
IT WAS REPORTED THAT DURING DEVICE PREPARATION OF A 4.5X60MM SUPERA SELF-EXPANDING STENT SYSTEM (SESS), THE DEVICE WAS BEING FLUSHED WHEN THE TIP BECAME SEPARATED. THE SESS WAS NOT USED FOR THE PROCEDURE. THERE WAS NO PATIENT INVOLVEMENT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. A 5X80MM ABSOLUTE PRO SELF-EXPANDING STENT SYSTEM (SESS) WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14018110 ↗MalfunctionJul 22, 2021Break; Leak/Splash; Break; Leak/Splash
IT WAS REPORTED THAT BEFORE THAT DURING PREPARATION, THE SHEATH PORT CRACKED WHEN DOING THE INITIAL FLUSH. SUBSEQUENTLY, WHEN THE DEVICE WAS BEING FLUSHED, CONTRAST WOULD SPRAY OUT OF THE SIDE WALL. THE DEVICE WAS NOT USED AND THERE WAS NO PATIENT INVOLVEMENT. ANOTHER SUPERA WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12211181 ↗MalfunctionAug 29, 2019Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MODERATELY CALCIFIED SUPERFICIAL FEMORAL ARTERY. A 4.5 X 60 MM SUPERA PERIPHERAL STENT SYSTEM WAS USED WITHOUT ANY ISSUES. HOWEVER, IT WAS NOTED AFTER IMPLANTATION THAT THE DEVICE HAD EXPIRED ON 06/30/ 2019. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8945245 ↗
Other STENT, SUPERFICIAL FEMORAL ARTERY devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page